Molecular aspects of arterial smooth muscle contraction: Focus on Rho

Experimental Biology and Medicine

Volumn 230, Issue 11, 2005, Pages 829-835

  Hilgers, Rob H P ^a   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Calcium; Contraction; Signaling; Smooth muscle; Vascular

Indexed keywords

CALCIUM ION; ION CHANNEL; MYOSIN; PHOSPHATASE; RHO FACTOR; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTERY MUSCLE; CELL FUNCTION; DEPHOSPHORYLATION; MOLECULAR BIOLOGY; MUSCLE CONTRACTION; MUSCLE RELAXATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSITIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 28944451809     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523001107     Document Type: Short Survey

References (66)

1. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487-517; 1995.
2. Woodrum DA, Brophy CM. The paradox of smooth muscle physiology. Mol Cell Endocrinol 177:135-143; 2001.
3. Ito M, Nakano T, Erdodi F, Hartshorne D. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 259:197-209; 2004.
4. Meiss R. Mechanisms of smooth muscle contraction. In: Kao CY, Carsten ME, Eds. Cellular Aspects of Smooth Muscle Function. New York: Cambridge University Press, pp169-201, 1997.
5. Wier W, Morgan K. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. Rev Physiol Biochem Pharmacol 150:91-139; 2003.
6. Ogut O, Brozovich FV. Regulation of force in vascular smooth muscle. J Mol Cell Cardiol 35:347-355; 2003.
7. Somlyo A, Somlyo A. Intracellular signaling in vascular smooth muscle. Adv Exp Med Biol 346:31-38; 1993.
8. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA. Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol 280:H1427-H1433; 2001.
9. Hill MA, Zou H, Potocnik SJ, Meininger GA, Davis MJ. Signal transduction in smooth muscle: arteriolar smooth muscle mechanotransduction: Ca2+ signaling pathways underlying myogenic reactivity (invited review). J Appl Physiol 91:973-983; 2001.
10. Adelstein R, Conti M. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature 256:597-598; 1975.
11. Gallagher P, Herring B, Stull J. Myosin light chain kinases. J Muscle Res Cell Motil 18:1-16; 1997.
12. Kamm K, Stull J. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25:593-620; 1985.
13. Hai C, Murphy R. Ca2+, crossbridge phosphorylation, and contraction. Annu Rev Physiol 51:285-298; 1989.
14. Barany M, Barany K. Protein phosphorylation during contraction and relaxation. In: Barany M, Ed. Biochemistry of Smooth Muscle Contraction. San Diego: Academic Press, Inc, pp321-339, 1996.
15. Kasai Y, Yamazawa T, Sakurai T, Taketani Y, Iino M. Endothelium-dependent frequency modulation of Ca2+ signalling in individual vascular smooth muscle cells of the rat. J Physiol 504:349-357; 1997.
16. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177-185; 2000.
17. Zhong H, Minneman K. Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375:261-276; 1999.
18. Bhattacharya S, Bunick CG, Chazin WJ. Target selectivity in EF-hand calcium binding proteins. Biochim Biophys Acta 1742:69-79; 2004.
19. Tanaka Y, Hata S, Ishiro H, Ishii K, Nakayama K. Stretching releases Ca2+ from intracellular storage sites in canine cerebral arteries. Can J Physiol Pharmacol 72:19-24; 1994.
20. Davis MJ, Hill MA. Signaling Mechanisms Underlying the Vascular Myogenic Response. Physiol Rev 79:387-423, 1999.
21. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 22:6027-6034; 2003.
22. Fukata Y, Kaibuchi K, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22:32-39; 2001.
23. Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. Circ Res 87:173-175; 2000.
24. Hartshorne D, Ito M, Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 19:325-341; 1998.
25. Ichikawa K, Hirano K, Ito M, Tanaka J, Nakano T, Hartshorne D. Interactions and properties of smooth muscle myosin phosphatase. Biochemistry 35:6313-6320; 1996.
26. Kitazawa T, Masuo M, Somlyo A. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci U S A 88:9307-9310; 1991.
27. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994; 1997.
28. Jackson E, Andresen B, Seasholtz T, Zhu C, Romero G. Enhanced activation of RhoA by angiotensin II in SHR preglomerular microvascular smooth muscle cells. J Cardiovasc Pharmacol 45:283-285; 2005.
29. Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16:1587-1609; 2002.
30. Leung T, Manser E, Tan L, Lim L. A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem 270:29051-29054; 1995.
31. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248; 1996.
32. Taggart MJ, Lee Y-H, Morgan KG. Cellular redistribution of PKCα, rhoA, and ROK α following smooth muscle agonist stimulation. Exp Cell Res 251:92-101; 1999.
33. Shin H-M, Je H-D, Gallant C, Tao TC, Hartshorne DJ, Ito M, Morgan KG. Differential association and localization of myosin phosphatase subunits during agonist-induced signal transduction in smooth muscle. Circ Res 90:546-553; 2002.
34. Shimomura E, Shiraishi M, Iwanaga T, Seto M, Sasaki Y, Ikeda M, Ito K. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta. Naunyn Schmiedebergs Arch Pharmacol 370:414-422; 2004.
35. Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 278:C57-C65; 2000.
36. Breitenlechner C, Gassel M, Hidaka H, Kinzel V, Huber R, Engh RA, Bossemeyer D. Protein kinase A in complex with Rho-kinase inhibitors Y-27632, fasudil, and H-1152P: structural basis of selectivity. Structure 11:1595-1607; 2003.
37. Ark M, Ozveren E, Yazici G, Korkmaz B, Buyukafsar K, Arikan O, Kubat H, Songu-Mize E. Effects of HA-1077 and Y-27632, two Rho-kinase inhibitors, in the human umbilical artery. Cell Biochem Biophys 41:331-342; 2004.
38. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. Hypertension 39:438-442; 2002.
39. Chitaley K, Weber D, Webb R. RhoA/Rho-kinase, vascular changes, and hypertension. Curr Hypertens Rep 3:139-144; 2001.
40. Somlyo A, Wu X, Walker L, Somlyo A. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 134:201-234; 1999.
41. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C: isolation from porcine aorta media and characterization. J Biochem (Tokyo) 118:1104-1107; 1995
42. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410:356-360; 1997.
43. Li L, Eto M, Lee MR, Morita F, Yazawa M, Kitazawa T. Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J Physiol 508:871-881; 1998.
44. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275:9897-9900; 2000.
45. Wu X, Haystead TAJ, Nakamoto RK, Somlyo AV, Somlyo AP. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin: synergism with cyclic nucleotide-activated kinase. J Biol Chem 273:11362-11369; 1998.
46. Choudhury N, Khromov A, Somlyo A, Somlyo A. Telokin mediates Ca(2+)-desensitization through activation of myosin phosphatase in phasic and tonic smooth muscle. J Muscle Res Cell Motil 25:657-665; 2004.
47. Thiesen S, Kubart S, Ropers H-H, Nothwang HG. Isolation of two novel human RhoGEFs, ARHGEF3 and ARHGEF4, in 3p13-21 and 2q22. Biochem Biophys Res Commun 273:364-369; 2000.
48. Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287:H1495-H1500; 2004.
49. Gunst S, Tang D. The contractile apparatus and mechanical properties of airway smooth muscle. Eur Respir J 15:600-616; 2000.
50. Gerthoffer WT, Gunst SJ. Signal transduction in smooth muscle (invited review): focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J Appl Physiol 91:963-972; 2001.
51. Tseng S, Kim R, Kim T, Morgan KG, Hai CM. F-actin disruption attenuates agonist-induced [Ca2+], myosin phosphorylation, and force in smooth muscle. Am J Physiol Cell Physiol 272:C1960-C1967; 1997.
52. Katsuyama H, Wang C, Morgan K. Regulation of vascular smooth muscle tone by caldesmon. J Biol Chem 267:14555-14558; 1992.
53. Winder S, Walsh M, Vasulka C, Johnson J. Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases. Biochemistry 32:13327-13333; 1993.
54. Sutherland C, Walsh M. Phosphorylation of caldesmon prevents its interaction with smooth muscle myosin. J Biol Chem 264:578-583; 1989.
55. Hedges JC, Oxhorn BC, Carty M, Adam LP, Yamboliev IA, Gerthoffer WT. Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am J Physiol Cell Physiol 278:C718-C726; 2000.
56. Yamboliev IA, Hedges JC, Mutnick JL-M, Adam LP, Gerthoffer WT. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 278:H1899-H1907; 2000.
57. Lavoie J, Hickey E, Weber L, Landry J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 268:24210-24214; 1993.
58. Zhang D, Jin N, Rhoades R, Yancey K, Swartz D. Influence of microtubules on vascular smooth muscle contraction. J Muscle Res Cell Motil 21:293-300; 2000.
59. Platts SH, Falcone JC, Holton WT, Hill MA, Meininger GA. Alteration of microtubule polymerization modulates arteriolar vasomotor tone. Am J Physiol Heart Circ Physiol 277:H100-H106; 1999.
60. Chitaley K, Webb RC. Microtubule depolymerization facilitates contraction of rat aorta via activation of Rho-kinase. Vascul Pharmacol 38:157-161; 2002.
61. Chitaley K, Webb R. Microtubule depolymerization facilitates contraction of vascular smooth muscle via increased activation of RhoA/Rho-kinase. Med Hypotheses 56:381-385; 2001.
62. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC, Lewis RL, Mills TM, Hellstrom WJG, Kadowitz PJ. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 101:9121-9126; 2004.
63. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, Takeshita A. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 15:1062-1064; 2001.
64. Kandabashi T, Shimokawa H, Mukai Y, Matoba T, Kunihiro I, Morikawa K, Ito M, Takahashi S, Kaibuchi K, Takeshita A. Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries. Arterioscler Thromb Vasc Biol 22:243-248; 2002.
65. Yoshii A, Iizuka K, Dobashi K, Horie T, Harada T, Nakazawa T, Mori M. Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol 20:1190-1200; 1999.
66. Seasholtz TM, Brown JH. Rho signaling in vascular diseases. Mol Interv 4:348-357; 2004.